Citation: Ij. Bahl et al., LOW-LOSS MULTILAYER MICROSTRIP LINE FOR MONOLITHIC MICROWAVE INTEGRATED-CIRCUITS APPLICATIONS, INTERNATIONAL JOURNAL OF RF AND MICROWAVE COMPUTER-AIDED ENGINEERING, 8(6), 1998, pp. 441-454
Authors:
CHECKOWAY H
FRANKLIN GM
COSTAMALLEN P
SMITHWELLER T
DILLEY J
SWANSON PD
COSTA LG
Citation: H. Checkoway et al., A GENETIC-POLYMORPHISM OF MAO-B MODIFIES THE ASSOCIATION OF CIGARETTE-SMOKING AND PARKINSONS-DISEASE, Neurology, 50(5), 1998, pp. 1458-1461
Citation: W. Mcfarland et al., ESTIMATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) SEROINCIDENCE AMONG REPEAT ANONYMOUS TESTERS IN SAN-FRANCISCO, American journal of epidemiology, 146(8), 1997, pp. 662-664
Citation: J. Dilley et D. Crawford, MASS DEPENDENCE OF ENERGY-LOSS IN COLLISIONS OF ICY SPHERES - AN EXPERIMENTAL-STUDY, J GEO R-PLA, 101(E4), 1996, pp. 9267-9270
Authors:
NARULA J
PETROV A
ODONNELL SM
DITLOW C
PIESLAK I
DILLEY J
CHEN F
KHAW BA
Citation: J. Narula et al., GAMMA-IMAGING OF ATHEROSCLEROTIC LESIONS - THE ROLE OF ANTIBODY-AFFINITY IN IN-VIVO TARGET LOCALIZATION, Journal of nuclear cardiology, 3(3), 1996, pp. 231-241
Authors:
NARULA J
PETROV A
BIANCHI C
DITLOW CC
LISTER BC
DILLEY J
PIESLAK I
CHEN FW
TORCHILIN VP
KHAW BA
Citation: J. Narula et al., NONINVASIVE LOCALIZATION OF EXPERIMENTAL ATHEROSCLEROTIC LESIONS WITHMOUSE-HUMAN CHIMERIC Z2D3 F(AB')(2) SPECIFIC FOR THE PROLIFERATING SMOOTH-MUSCLE CELLS OF HUMAN ATHEROMA - IMAGING WITH CONVENTIONAL AND NEGATIVE CHARGE-MODIFIED ANTIBODY FRAGMENTS, Circulation, 92(3), 1995, pp. 474-484
Authors:
HEUSER L
DILLEY J
MADDURI H
RABIN S
WOODS S
Citation: L. Heuser et al., DEVELOPMENT OF DISTRIBUTED AND CLIENT-SERVER OBJECT-ORIENTED APPLICATIONS - INDUSTRY SOLUTIONS, ACM SIGPLAN NOTICES, 29(10), 1994, pp. 317-323
Authors:
NARULA J
PETROV A
DITLOW C
DILLEY J
PIESLAK I
CHEN FW
KHAW BA
Citation: J. Narula et al., EARLIER EXPERIMENTAL ATHEROSCLEROTIC LESION VISUALIZATION WITH HIGH RADIOSPECIFIC-ACTIVITY, NEGATIVE CHARGE-MODIFIED CHIMERIC Z2D3 F(AB')(2) (AT 24 HOURS) VERSUS CONVENTIONALLY LABELED-ANTIBODY (AT 48 HOURS), The Journal of nuclear medicine, 35(5), 1994, pp. 160000098-160000098